MAPK3 and non-small cell lung carcinoma: RAF/MEK/ERK is found to contribute to NSCLC through YAP modulation, since the anti-ERK1/2 siRNA strategy discussed earlier led to a decrease in migration and an invasion of NSCLC cells, along with the decrease in YAP protein expression observed [65].